HistoGenetics
HistoGenetics provides cost-effective HLA sequence-based typing services based on the latest state-of-the-art robotics and bioinformatics technologies for donor registries, pharmacogenomics, donor centers, cord blood typing, transplant centers, and HLA laboratories around the world. Through a proprietary process developed by Dr. Soo Young Yang and Dr. Nezih Cereb, HistoGenetics provides high- and low-throughput molecular tissue typing services at their high-tech facilities in the New York metropolitan area with an emphasis on extremely high quality and fast turnaround times.
Last updated on
About HistoGenetics
Founded
1999Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$1MCategory
Sector
Medical LaboratoriesIndustry Group
Medical and Dental LaboratoriesIndustry
Health ServicesLocation
City
OssiningState
New YorkCountry
United StatesHistoGenetics
Find your buyer within HistoGenetics